Salvage radiotherapy for rising or persistent PSA after radical prostatectomy.

[1]  D. Kuban,et al.  Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. , 2001, International journal of radiation oncology, biology, physics.

[2]  Christopher U. Jones,et al.  A phase III trial comparing whole-pelvic (WP) to prostate only (PO) radiotherapy and neoadjuvant to adjuvant total androgen suppression (TAS): preliminary analysis of RTOG 9413 , 2001 .

[3]  J. Pouliot,et al.  Online image guided external beam radiation therapy for the treatment prostate cancer using electronic portal imaging: prostate motion and setup evaluation , 2001 .

[4]  S. Schild.  Radiation therapy (RT) after prostatectomy: The case for salvage therapy as opposed to adjuvant therapy , 2001, International journal of cancer.

[5]  C. Catton,et al.  Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  R. Allison,et al.  Multimodality salvage for patients with persistently elevated postprostatectomy PSA , 2000, International journal of cancer.

[7]  D W Hillman,et al.  Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. , 2000, The Journal of urology.

[8]  T. J. Robnett,et al.  PSA based review of adjuvant and salvage radiation therapy vs. observation in postoperative prostate cancer patients , 2000, International journal of cancer.

[9]  P. Carroll,et al.  Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns. , 1999, Urology.

[10]  Baba,et al.  Efficacy and limitations of delayed/salvage radiation therapy after radical prostatectomy , 1999, Prostate cancer and prostatic diseases.

[11]  B. Corn,et al.  Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group. , 1999, Urology.

[12]  F. Vicini,et al.  Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer. , 1999, Urology.

[13]  A. Partin,et al.  Natural history of progression after PSA elevation following radical prostatectomy. , 1999, JAMA.

[14]  P. Schellhammer,et al.  Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  D. Ornstein,et al.  Evaluation and management of men whose radical prostatectomies failed: results of an international survey. , 1998, Urology.

[16]  B W Corn,et al.  Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer. , 1998, International journal of radiation oncology, biology, physics.

[17]  R. Parker,et al.  Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy. , 1998, The cancer journal from Scientific American.

[18]  M. Bagshaw.  Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer , 1998, International journal of radiation oncology, biology, physics.

[19]  J. Forman,et al.  Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy. , 1998, Urology.

[20]  N. Sanfilippo,et al.  Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation. , 1997, International journal of radiation oncology, biology, physics.

[21]  M. Zelefsky,et al.  Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. , 1997, International journal of radiation oncology, biology, physics.

[22]  A W Partin,et al.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.

[23]  S. Schild,et al.  The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. , 1996, The Journal of urology.

[24]  S. Levitt,et al.  Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy: A long term follow‐up , 1996 .

[25]  M. Barry,et al.  Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. , 1996, Journal of the National Cancer Institute.

[26]  V. Hárs,et al.  Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy. , 1996, Urology.

[27]  J. Oesterling,et al.  Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  A. Partin,et al.  Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. , 1994, The Journal of urology.

[29]  W. Catalona,et al.  Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment. , 1994, The Journal of urology.

[30]  A W Partin,et al.  Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. , 1993, The Urologic clinics of North America.

[31]  I. Kaplan,et al.  Serum prostate-specific antigen after post-prostatectomy radiotherapy. , 1992, Urology.

[32]  T. Stamey,et al.  Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. , 1991, The Journal of urology.

[33]  P. Grigsby,et al.  Preliminary report on 10 patients treated with radiotherapy after radical prostatectomy for isolated elevation of serum PSA levels. , 1990, International journal of radiation oncology, biology, physics.

[34]  R. Vessella,et al.  The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. , 1990, The Journal of urology.

[35]  P. Lange,et al.  Prostate specific antigen and local recurrence after radical prostatectomy. , 1990, The Journal of urology.

[36]  W. Catalona,et al.  Effect of adjuvant radiation therapy on prostate specific antigen following radical prostatectomy. , 1990, The Journal of urology.

[37]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[38]  M S Anscher,et al.  Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years. , 2000, International journal of radiation oncology, biology, physics.

[39]  J. Cadeddu,et al.  Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. , 1998, The Journal of urology.

[40]  J. Forman,et al.  Therapeutic radiation in patients with a rising post-prostatectomy PSA level. , 1998, Oncology.

[41]  A. Zietman,et al.  Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[42]  D. Cox.  Regression Models and Life-Tables , 1972 .